Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025 - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025 - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) presents Vutrisiran ATTR-CM data at ACC.26 - MSN

Alnylam Pharmaceuticals (ALNY) presents Vutrisiran ATTR-CM data at ACC.26  MSN

Alnylam Pharmaceuticals (ALNY) presents Vutrisiran ATTR-CM data at ACC.26 - MSN

Click here to get full coverage on ALNY (Alnylam Pharmaceuticals) Earnings Yield (Joel Greenblatt) % : 1.13% (As of Dec. 2025) - GuruFocus

ALNY (Alnylam Pharmaceuticals) Earnings Yield (Joel Greenblatt) % : 1.13% (As of Dec. 2025)  GuruFocus

ALNY (Alnylam Pharmaceuticals) Earnings Yield (Joel Greenblatt) % : 1.13% (As of Dec. 2025) - GuruFocus

Click here to get full coverage on Alnylam (NASDAQ: ALNY) HR chief details stock and option holdings - Stock Titan

Alnylam (NASDAQ: ALNY) HR chief details stock and option holdings  Stock Titan

Alnylam (NASDAQ: ALNY) HR chief details stock and option holdings - Stock Titan

Click here to get full coverage on How New Vutrisiran Outcomes and Zilebesiran Safety Data Will Impact Alnylam Pharmaceuticals (ALNY) Investors - simplywall.st

How New Vutrisiran Outcomes and Zilebesiran Safety Data Will Impact Alnylam Pharmaceuticals (ALNY) Investors  simplywall.st

How New Vutrisiran Outcomes and Zilebesiran Safety Data Will Impact Alnylam Pharmaceuticals (ALNY) Investors - simplywall.st

Click here to get full coverage on Trading Systems Reacting to (ALNY) Volatility - Stock Traders Daily

Trading Systems Reacting to (ALNY) Volatility  Stock Traders Daily

Trading Systems Reacting to (ALNY) Volatility - Stock Traders Daily

Click here to get full coverage on Alnylam (ALNY) jumps 6.7% as investors refocus on TTR franchise after company webinar | ALNY Stock News - Quiver Quantitative

Alnylam (ALNY) jumps 6.7% as investors refocus on TTR franchise after company webinar | ALNY Stock News  Quiver Quantitative

Alnylam (ALNY) jumps 6.7% as investors refocus on TTR franchise after company webinar | ALNY Stock News - Quiver Quantitative

Click here to get full coverage on Is the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock? - TradingView

Is the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock?  TradingView

Is the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock? - TradingView

Click here to get full coverage on Alnylam (NASDAQ: ALNY) HR chief auto-sells shares to cover RSU taxes - Stock Titan

Alnylam (NASDAQ: ALNY) HR chief auto-sells shares to cover RSU taxes  Stock Titan

Alnylam (NASDAQ: ALNY) HR chief auto-sells shares to cover RSU taxes - Stock Titan

Click here to get full coverage on [144] ALNYLAM PHARMACEUTICALS, INC. SEC Filing - Stock Titan

[144] ALNYLAM PHARMACEUTICALS, INC. SEC Filing  Stock Titan

[144] ALNYLAM PHARMACEUTICALS, INC. SEC Filing - Stock Titan

Click here to get full coverage on Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now - Yahoo Finance

Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now  Yahoo Finance

Why Alnylam Pharmaceuticals Inc. (ALNY) is One of the Best High Growth Healthcare Stocks to Buy Now - Yahoo Finance

Click here to get full coverage on Alnylam (NASDAQ: ALNY) sets 2026 virtual meeting, board elections and pay vote - Stock Titan

Alnylam (NASDAQ: ALNY) sets 2026 virtual meeting, board elections and pay vote  Stock Titan

Alnylam (NASDAQ: ALNY) sets 2026 virtual meeting, board elections and pay vote - Stock Titan

Click here to get full coverage on Alnylam (ALNY) Targets 25% CAGR with Innovative Therapies - Yahoo Finance

Alnylam (ALNY) Targets 25% CAGR with Innovative Therapies  Yahoo Finance

Alnylam (ALNY) Targets 25% CAGR with Innovative Therapies - Yahoo Finance

Click here to get full coverage on Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now? - Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now?  Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) One of the Best Upside Stocks to Invest In Right Now? - Yahoo Finance

Click here to get full coverage on Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Have A Healthy Balance Sheet? - Yahoo Finance

Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Have A Healthy Balance Sheet?  Yahoo Finance

Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Have A Healthy Balance Sheet? - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal - Yahoo Finance

Click here to get full coverage on Alnylam (ALNY) CHRO McLaughlin sells shares worth $1.27 million By Investing.com - Investing.com India

Alnylam (ALNY) CHRO McLaughlin sells shares worth $1.27 million By Investing.com  Investing.com India

Alnylam (ALNY) CHRO McLaughlin sells shares worth $1.27 million By Investing.com - Investing.com India

Click here to get full coverage on A Look At Alnylam Pharmaceuticals (ALNY) Valuation After New Cardiovascular Data And Partnerships At ACC.26 - simplywall.st

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After New Cardiovascular Data And Partnerships At ACC.26  simplywall.st

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After New Cardiovascular Data And Partnerships At ACC.26 - simplywall.st

Click here to get full coverage on ALNY Jun 2026 490.000 call (ALNY260618C00490000) Stock Historical Prices & Data - Yahoo! Finance Canada

ALNY Jun 2026 490.000 call (ALNY260618C00490000) Stock Historical Prices & Data  Yahoo! Finance Canada

ALNY Jun 2026 490.000 call (ALNY260618C00490000) Stock Historical Prices & Data - Yahoo! Finance Canada

Click here to get full coverage on Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models - Yahoo Finance

Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models  Yahoo Finance

Assessing Alnylam Pharmaceuticals (ALNY) Valuation As Mixed Share Price Returns Meet Bullish Fair Value Models - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise - Slideshow (NASDAQ:ALNY) 2026-03-26 - Seeking Alpha

Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise - Slideshow (NASDAQ:ALNY) 2026-03-26  Seeking Alpha

Alnylam Pharmaceuticals, Inc. (ALNY) Discusses Progress and Strategy in Transforming ATTR Amyloidosis Care and Expanding TTR Franchise - Slideshow (NASDAQ:ALNY) 2026-03-26 - Seeking Alpha

Click here to get full coverage on Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth - Yahoo Finance

Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth  Yahoo Finance

Analysts Trim Alnylam Pharmaceuticals, Inc. (ALNY) Targets but Keep Faith in 2026 Growth - Yahoo Finance

Click here to get full coverage on RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $450 - 富途牛牛

RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $450  富途牛牛

RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $450 - 富途牛牛

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Reports $3B 2025 Revenue Driven by 151% TTR Franchise Surge - Yahoo Finance

Click here to get full coverage on Here’s the somewhat surprising stock that will soon join the S&P 500 - MarketWatch

Here’s the somewhat surprising stock that will soon join the S&P 500  MarketWatch

Here’s the somewhat surprising stock that will soon join the S&P 500 - MarketWatch

Click here to get full coverage on Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock - Yahoo Finance

Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock  Yahoo Finance

Canaccord Genuity Maintains Buy Rating on Alnylam Pharmaceuticals, Inc. (ALNY) Stock - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly - Yahoo Finance

Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly  Yahoo Finance

Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly - Yahoo Finance

Click here to get full coverage on Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth - Yahoo Finance

Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth  Yahoo Finance

Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth - Yahoo Finance

Click here to get full coverage on Alnylam backs AI screening and a 10-site effort for missed heart disease - Stock Titan

Alnylam backs AI screening and a 10-site effort for missed heart disease  Stock Titan

Alnylam backs AI screening and a 10-site effort for missed heart disease - Stock Titan

Click here to get full coverage on Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance

Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Click here to get full coverage on Is It Time To Reassess Alnylam Pharmaceuticals (ALNY) After The Recent Share Price Pullback - Yahoo Finance

Is It Time To Reassess Alnylam Pharmaceuticals (ALNY) After The Recent Share Price Pullback  Yahoo Finance

Is It Time To Reassess Alnylam Pharmaceuticals (ALNY) After The Recent Share Price Pullback - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue Guidance - Yahoo Finance

Alnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue Guidance  Yahoo Finance

Alnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue Guidance - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) Combines Strong Growth with a Technical Breakout Setup - ChartMill

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) Combines Strong Growth with a Technical Breakout Setup  ChartMill

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) Combines Strong Growth with a Technical Breakout Setup - ChartMill

Click here to get full coverage on Here’s What Boosted Alnylam Pharmaceuticals (ALNY) in Q3 - Yahoo Finance

Here’s What Boosted Alnylam Pharmaceuticals (ALNY) in Q3  Yahoo Finance

Here’s What Boosted Alnylam Pharmaceuticals (ALNY) in Q3 - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Surged on Strong Growth and Optimistic Revenue Outlook - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Surged on Strong Growth and Optimistic Revenue Outlook  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Surged on Strong Growth and Optimistic Revenue Outlook - Yahoo Finance

Click here to get full coverage on Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 49% Undervaluation? - Yahoo Finance

Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 49% Undervaluation?  Yahoo Finance

Is There An Opportunity With Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 49% Undervaluation? - Yahoo Finance

Click here to get full coverage on Is It Time To Reassess Alnylam (ALNY) After Recent Share Price Pullback? - Yahoo Finance

Is It Time To Reassess Alnylam (ALNY) After Recent Share Price Pullback?  Yahoo Finance

Is It Time To Reassess Alnylam (ALNY) After Recent Share Price Pullback? - Yahoo Finance

Click here to get full coverage on Down 34% From All-Time Highs, Can Alnylam Pharmaceuticals Stock Finally Recover In 2026? - TIKR.com

Down 34% From All-Time Highs, Can Alnylam Pharmaceuticals Stock Finally Recover In 2026?  TIKR.com

Down 34% From All-Time Highs, Can Alnylam Pharmaceuticals Stock Finally Recover In 2026? - TIKR.com

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy?  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Earnings Expected to Grow: Should You Buy? - Yahoo Finance

Click here to get full coverage on ALNYLAM PHARMACEUTICALS Q4 2025 Earnings Preview: Recent $ALNY Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

ALNYLAM PHARMACEUTICALS Q4 2025 Earnings Preview: Recent $ALNY Insider Trading, Hedge Fund Activity, and More  Quiver Quantitative

ALNYLAM PHARMACEUTICALS Q4 2025 Earnings Preview: Recent $ALNY Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Click here to get full coverage on Why Alnylam Pharmaceuticals (ALNY) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Why Alnylam Pharmaceuticals (ALNY) is a Top Momentum Stock for the Long-Term  Yahoo Finance

Why Alnylam Pharmaceuticals (ALNY) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on Does Alnylam Pharmaceuticals (ALNY) Price Reflect Its RNAi Pipeline Potential? - Yahoo Finance

Does Alnylam Pharmaceuticals (ALNY) Price Reflect Its RNAi Pipeline Potential?  Yahoo Finance

Does Alnylam Pharmaceuticals (ALNY) Price Reflect Its RNAi Pipeline Potential? - Yahoo Finance

Click here to get full coverage on Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth? - Yahoo Finance

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?  Yahoo Finance

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth? - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals: Challenges In The TTR Space And Few Late-Stage Catalysts Are A Concern - Seeking Alpha

Alnylam Pharmaceuticals: Challenges In The TTR Space And Few Late-Stage Catalysts Are A Concern  Seeking Alpha

Alnylam Pharmaceuticals: Challenges In The TTR Space And Few Late-Stage Catalysts Are A Concern - Seeking Alpha

Click here to get full coverage on Wells Fargo Raises Alnylam (ALNY) Revenue Estimates for Amvuttra Despite Projected Margin Compression - Yahoo Finance

Wells Fargo Raises Alnylam (ALNY) Revenue Estimates for Amvuttra Despite Projected Margin Compression  Yahoo Finance

Wells Fargo Raises Alnylam (ALNY) Revenue Estimates for Amvuttra Despite Projected Margin Compression - Yahoo Finance

Click here to get full coverage on Alnylam heart drug showed gains seen in patients 11 years younger - Stock Titan

Alnylam heart drug showed gains seen in patients 11 years younger  Stock Titan

Alnylam heart drug showed gains seen in patients 11 years younger - Stock Titan

Click here to get full coverage on ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down - Yahoo Finance

ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down  Yahoo Finance

ALNY Q4 Earnings Beat, Sales Miss Despite Y/Y Growth, Stock Down - Yahoo Finance

Click here to get full coverage on Is It Time To Revisit Alnylam Pharmaceuticals (ALNY) After Recent Share Price Pullback - simplywall.st

Is It Time To Revisit Alnylam Pharmaceuticals (ALNY) After Recent Share Price Pullback  simplywall.st

Is It Time To Revisit Alnylam Pharmaceuticals (ALNY) After Recent Share Price Pullback - simplywall.st

Click here to get full coverage on Countdown to Alnylam (ALNY) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance

Countdown to Alnylam (ALNY) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS  Yahoo Finance

Countdown to Alnylam (ALNY) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS - Yahoo Finance

Click here to get full coverage on Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock - Yahoo Finance

Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock  Yahoo Finance

Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum Stock - Yahoo Finance

Click here to get full coverage on Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations (ALNY) - Seeking Alpha

Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations (ALNY)  Seeking Alpha

Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations (ALNY) - Seeking Alpha

Click here to get full coverage on Vanguard amends 13G/A; reports 0 shares in Alnylam (ALNY) - Stock Titan

Vanguard amends 13G/A; reports 0 shares in Alnylam (ALNY)  Stock Titan

Vanguard amends 13G/A; reports 0 shares in Alnylam (ALNY) - Stock Titan

Click here to get full coverage on Alnylam Data Update Highlights RNAi Potential And Undervalued Share Price - simplywall.st

Alnylam Data Update Highlights RNAi Potential And Undervalued Share Price  simplywall.st

Alnylam Data Update Highlights RNAi Potential And Undervalued Share Price - simplywall.st

Click here to get full coverage on How Alnylam Pharmaceuticals Inc. (ALNY) Affects Rotational Strategy Timing - Stock Traders Daily

How Alnylam Pharmaceuticals Inc. (ALNY) Affects Rotational Strategy Timing  Stock Traders Daily

How Alnylam Pharmaceuticals Inc. (ALNY) Affects Rotational Strategy Timing - Stock Traders Daily

Click here to get full coverage on Alnylam (ALNY) CCO receives 1,666 shares from RSU vesting - Stock Titan

Alnylam (ALNY) CCO receives 1,666 shares from RSU vesting  Stock Titan

Alnylam (ALNY) CCO receives 1,666 shares from RSU vesting - Stock Titan

Click here to get full coverage on Wealth Enhancement Slashes Alnylam Pharmaceuticals, Inc. (ALNY) Stake by 64.5% - Yahoo Finance

Wealth Enhancement Slashes Alnylam Pharmaceuticals, Inc. (ALNY) Stake by 64.5%  Yahoo Finance

Wealth Enhancement Slashes Alnylam Pharmaceuticals, Inc. (ALNY) Stake by 64.5% - Yahoo Finance

Click here to get full coverage on Alnylam shares jump as investors focus on profitability and upbeat 2026 revenue outlook | ALNY Stock News - Quiver Quantitative

Alnylam shares jump as investors focus on profitability and upbeat 2026 revenue outlook | ALNY Stock News  Quiver Quantitative

Alnylam shares jump as investors focus on profitability and upbeat 2026 revenue outlook | ALNY Stock News - Quiver Quantitative

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Turns Profitable With Q4 EPS Of US$1.41 Challenging Bearish Narratives - simplywall.st

Alnylam Pharmaceuticals (ALNY) Turns Profitable With Q4 EPS Of US$1.41 Challenging Bearish Narratives  simplywall.st

Alnylam Pharmaceuticals (ALNY) Turns Profitable With Q4 EPS Of US$1.41 Challenging Bearish Narratives - simplywall.st

Click here to get full coverage on Alnylam Achieves Leading Trading Position Despite Declining Volume as Revenue Surges - Bitget

Alnylam Achieves Leading Trading Position Despite Declining Volume as Revenue Surges  Bitget

Alnylam Achieves Leading Trading Position Despite Declining Volume as Revenue Surges - Bitget

Click here to get full coverage on Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPS - Yahoo Finance

Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPS  Yahoo Finance

Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPS - Yahoo Finance

Click here to get full coverage on Is Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 19% ROE Better Than Average? - Yahoo Finance

Is Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 19% ROE Better Than Average?  Yahoo Finance

Is Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 19% ROE Better Than Average? - Yahoo Finance

Click here to get full coverage on A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness - Yahoo Finance

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness  Yahoo Finance

A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Share Price Weakness - Yahoo Finance

Click here to get full coverage on Why Alnylam (ALNY) Might be Well Poised for a Surge - Yahoo Finance

Why Alnylam (ALNY) Might be Well Poised for a Surge  Yahoo Finance

Why Alnylam (ALNY) Might be Well Poised for a Surge - Yahoo Finance

Click here to get full coverage on ALNY Q3 Earnings and Revenues Top Estimates on Higher Amvuttra Sales - Yahoo Finance

ALNY Q3 Earnings and Revenues Top Estimates on Higher Amvuttra Sales  Yahoo Finance

ALNY Q3 Earnings and Revenues Top Estimates on Higher Amvuttra Sales - Yahoo Finance

Click here to get full coverage on Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates  Yahoo Finance

Alnylam Pharmaceuticals (ALNY) Surpasses Q4 Earnings Estimates - Yahoo Finance

Click here to get full coverage on Is the options market signaling a potential surge in Alnylam Pharmaceuticals shares? - Bitget

Is the options market signaling a potential surge in Alnylam Pharmaceuticals shares?  Bitget

Is the options market signaling a potential surge in Alnylam Pharmaceuticals shares? - Bitget

Click here to get full coverage on Alnylam (ALNY) CHRO McLaughlin sells shares worth $1.27 million By Investing.com - Investing.com Australia

Alnylam (ALNY) CHRO McLaughlin sells shares worth $1.27 million By Investing.com  Investing.com Australia

ALNY

Price Chart

Key Statistics

Technicals

About ALNY

Latest News

Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025 - Yahoo Finance

Alnylam Pharmaceuticals (ALNY) presents Vutrisiran ATTR-CM data at ACC.26 - MSN

ALNY (Alnylam Pharmaceuticals) Earnings Yield (Joel Greenblatt) % : 1.13% (As of Dec. 2025) - GuruFocus

Advanced Charts

Top Gainers

Top Losers